Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Diehl, Philipp"" wg kryterium: Autor


Tytuł :
A DARPin targeting activated Mac-1 is a novel diagnostic tool and potential anti-inflammatory agent in myocarditis, sepsis and myocardial infarction.
Autorzy :
Siegel PM; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
Bojti I; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Bassler N; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
Holien J; ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Melbourne, Australia.
Flierl U; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
Wang X; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.; Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia.; Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia.
Waggershauser P; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Tonnar X; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Vedecnik C; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Lamprecht C; BIOSS Centre for Biological Signalling Studies/Synthetic Biology of Signalling Processes, University of Freiburg, Freiburg, Germany.
Stankova I; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Li T; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Helbing T; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Wolf D; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Anto-Michel N; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Mitre LS; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Ehrlich J; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Orlean L; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Bender I; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Przewosnik A; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Mauler M; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Hollederer L; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Moser M; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Bode C; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Parker MW; ACRF Rational Drug Discovery Centre, St. Vincent's Institute of Medical Research, Melbourne, Australia.; Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia.; Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Melbourne, Australia.
Peter K; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia. .; Baker Department of Cardiometabolic Health, University of Melbourne, Melbourne, Australia. .; Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia. .; Baker Heart and Diabetes Institute, 75 Commercial Road, Melbourne, VIC, 3004, Australia. .
Diehl P; Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Atherothrombosis and Vascular Biology Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.; Department of Medicine, Central Clinical School, Monash University, Melbourne, Australia.
Pokaż więcej
Źródło :
Basic research in cardiology [Basic Res Cardiol] 2021 Mar 15; Vol. 116 (1), pp. 17. Date of Electronic Publication: 2021 Mar 15.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
Czasopismo naukowe
Tytuł :
Annexin V positive microvesicles are elevated and correlate with flow rate in patients receiving veno-arterial extracorporeal membrane oxygenation.
Autorzy :
Siegel PM; Department of Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, Freiburg, Germany.
Hentschel D; Department of Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, Freiburg, Germany.
Bojti I; Department of Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, Freiburg, Germany.
Wengenmayer T; Department of Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, Freiburg, Germany.
Helbing T; Department of Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, Freiburg, Germany.
Moser M; Department of Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, Freiburg, Germany.
Duerschmied D; Department of Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, Freiburg, Germany.
Trummer G; Department of Cardiovascular Surgery, Heart Center Freiburg University, Medical Faculty, University of Freiburg, Freiburg, Germany.
Bode C; Department of Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, Freiburg, Germany.
Diehl P; Department of Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, Freiburg, Germany.
Pokaż więcej
Źródło :
Interactive cardiovascular and thoracic surgery [Interact Cardiovasc Thorac Surg] 2020 Dec 07; Vol. 31 (6), pp. 884-891.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Health Status*
Annexin A5/*blood
Critical Illness/*therapy
Extracorporeal Membrane Oxygenation/*methods
Hemodynamics/*physiology
Biomarkers/blood ; Female ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Endothelial BMP4 Promotes Leukocyte Rolling and Adhesion and Is Elevated in Patients After Survived Out-of-Hospital Cardiac Arrest.
Autorzy :
Arnold L; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Weberbauer M; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Herkel M; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Fink K; Department of Emergency Medicine, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Busch HJ; Department of Emergency Medicine, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Diehl P; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Grundmann S; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Bode C; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Elsässer A; Department of Cardiology, Heart Center Oldenburg, Carl von Ossietzky University, Oldenburg, Germany.
Moser M; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Helbing T; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany. .; Department of Cardiology, Heart Center Oldenburg, Carl von Ossietzky University, Oldenburg, Germany. .
Pokaż więcej
Źródło :
Inflammation [Inflammation] 2020 Dec; Vol. 43 (6), pp. 2379-2391.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Cardiomyocyte microvesicles: proinflammatory mediators after myocardial ischemia?
Autorzy :
Siegel PM; Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, 79106, Freiburg im Breisgau, Germany. .; Baker Heart & Diabetes Institute, Atherothrombosis & Vascular Biology Laboratory, Melbourne, Australia. .
Schmich J; Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, 79106, Freiburg im Breisgau, Germany.; Baker Heart & Diabetes Institute, Atherothrombosis & Vascular Biology Laboratory, Melbourne, Australia.
Barinov G; Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, 79106, Freiburg im Breisgau, Germany.
Bojti I; Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, 79106, Freiburg im Breisgau, Germany.
Vedecnik C; Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, 79106, Freiburg im Breisgau, Germany.
Simanjuntak NR; Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, 79106, Freiburg im Breisgau, Germany.
Bode C; Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, 79106, Freiburg im Breisgau, Germany.
Moser M; Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, 79106, Freiburg im Breisgau, Germany.
Peter K; Baker Heart & Diabetes Institute, Atherothrombosis & Vascular Biology Laboratory, Melbourne, Australia.; Faculty for Medicine & Nursing, Monash University, Melbourne, Australia.
Diehl P; Cardiology and Angiology I, Heart Center Freiburg University, Medical Faculty, University of Freiburg, 79106, Freiburg im Breisgau, Germany.; Baker Heart & Diabetes Institute, Atherothrombosis & Vascular Biology Laboratory, Melbourne, Australia.; Faculty for Medicine & Nursing, Monash University, Melbourne, Australia.
Pokaż więcej
Źródło :
Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2020 Oct; Vol. 50 (3), pp. 533-542.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Dysregulation of the Mitochondrial Proteome Occurs in Mice Lacking Adiponectin Receptor 1.
Autorzy :
Pepin ME; Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Koentges C; Division of Cardiology and Angiology I, Heart Center Freiburg University, Freiburg, Germany.
Pfeil K; Division of Cardiology, Medical University of Graz, Graz, Austria.
Gollmer J; Division of Cardiology, Medical University of Graz, Graz, Austria.
Kersting S; Division of Cardiology and Angiology I, Heart Center Freiburg University, Freiburg, Germany.
Wiese S; Core Unit Mass Spectrometry and Proteomics, Ulm University, Ulm, Germany.
Hoffmann MM; Institute for Clinical Chemistry and Laboratory Medicine, Medical Center, University of Freiburg, Freiburg, Germany.
Odening KE; Division of Cardiology and Angiology I, Heart Center Freiburg University, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
von Zur Mühlen C; Division of Cardiology and Angiology I, Heart Center Freiburg University, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Diehl P; Division of Cardiology and Angiology I, Heart Center Freiburg University, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Stachon P; Division of Cardiology and Angiology I, Heart Center Freiburg University, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Wolf D; Division of Cardiology and Angiology I, Heart Center Freiburg University, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Wende AR; Division of Molecular and Cellular Pathology, Department of Pathology, University of Alabama at Birmingham, Birmingham, AL, United States.
Bode C; Division of Cardiology and Angiology I, Heart Center Freiburg University, Freiburg, Germany.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Zirlik A; Division of Cardiology and Angiology I, Heart Center Freiburg University, Freiburg, Germany.; Division of Cardiology, Medical University of Graz, Graz, Austria.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Bugger H; Division of Cardiology and Angiology I, Heart Center Freiburg University, Freiburg, Germany.; Division of Cardiology, Medical University of Graz, Graz, Austria.; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Pokaż więcej
Źródło :
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2019 Dec 13; Vol. 10, pp. 872. Date of Electronic Publication: 2019 Dec 13 (Print Publication: 2019).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
The Cardia Ultraseal Left Atrial Appendage Occluder: A Case Series With Significant Device-Related Complications.
Autorzy :
Ahlgrimm B
Pottgiesser T
Stachon P
Zehender M
Bugger H
Helbing T
Siepe M
Grundmann S
Bode C
Diehl P
Pokaż więcej
Źródło :
JACC. Cardiovascular interventions [JACC Cardiovasc Interv] 2019 Oct 14; Vol. 12 (19), pp. 1987-1989.
Typ publikacji :
Letter
MeSH Terms :
Prosthesis Failure*
Atrial Appendage/*physiopathology
Atrial Fibrillation/*therapy
Cardiac Catheterization/*instrumentation
Atrial Appendage/diagnostic imaging ; Atrial Fibrillation/diagnosis ; Atrial Fibrillation/physiopathology ; Atrial Function, Left ; Cardiac Catheterization/adverse effects ; Humans ; Prosthesis Design ; Risk Factors ; Time Factors ; Treatment Outcome
Opinia redakcyjna
Tytuł :
Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability.
Autorzy :
Diehl P; Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia.; Department of Cardiology and Angiology I, Faculty of Medicine, Heart Center - University of Freiburg, University of Freiburg, Freiburg, Germany.
Nienaber F; Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia.
Zaldivia MTK; Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia.
Stamm J; Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia.
Siegel PM; Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia.; Department of Cardiology and Angiology I, Faculty of Medicine, Heart Center - University of Freiburg, University of Freiburg, Freiburg, Germany.
Mellett NA; Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
Wessinger M; Department of Cardiology and Angiology I, Faculty of Medicine, Heart Center - University of Freiburg, University of Freiburg, Freiburg, Germany.
Wang X; Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia.
McFadyen JD; Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia.
Bassler N; Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia.
Puetz G; Institute for Clinical Chemistry and Laboratory Medicine, University of Freiburg, Freiburg, Germany.
Htun NM; Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia.
Braig D; Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia.; Department of Plastic and Hand Surgery, University of Freiburg, Freiburg, Germany.
Habersberger J; Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia.
Helbing T; Department of Cardiology and Angiology I, Faculty of Medicine, Heart Center - University of Freiburg, University of Freiburg, Freiburg, Germany.
Eisenhardt SU; Department of Plastic and Hand Surgery, University of Freiburg, Freiburg, Germany.
Fuller M; Centre for Molecular Pathology, University of Adelaide, Adelaide, Australia.
Bode C; Department of Cardiology and Angiology I, Faculty of Medicine, Heart Center - University of Freiburg, University of Freiburg, Freiburg, Germany.
Meikle PJ; Metabolomics Laboratory, Baker Heart and Diabetes Institute, Melbourne, Australia.
Chen YC; Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia.
Peter K; Department of Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, Australia.
Pokaż więcej
Źródło :
Thrombosis and haemostasis [Thromb Haemost] 2019 Aug; Vol. 119 (8), pp. 1295-1310. Date of Electronic Publication: 2019 Aug 02.
Typ publikacji :
Journal Article
MeSH Terms :
Atherosclerosis/*metabolism
Blood Platelets/*metabolism
Cell-Derived Microparticles/*metabolism
Lysophosphatidylcholines/*analysis
Animals ; Cell Movement ; Cells, Cultured ; Gene Expression Regulation ; Humans ; Inflammation ; Lipids/chemistry ; Mass Spectrometry ; Mice ; Microscopy, Fluorescence ; Monocytes/cytology ; Permeability ; Plaque, Atherosclerotic/metabolism ; Platelet Activation ; Platelet Aggregation
Czasopismo naukowe
Tytuł :
Semaphorin 3F Promotes Transendothelial Migration of Leukocytes in the Inflammatory Response After Survived Cardiac Arrest.
Autorzy :
Reichert S; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Scheid S; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Roth T; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Herkel M; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Petrova D; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Linden A; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Weberbauer M; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Esser J; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Diehl P; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Grundmann S; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Busch HJ; Department of Emergency Medicine, University Hospital of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Fink K; Department of Emergency Medicine, University Hospital of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Bode C; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Moser M; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Helbing T; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany. .
Pokaż więcej
Źródło :
Inflammation [Inflammation] 2019 Aug; Vol. 42 (4), pp. 1252-1264.
Typ publikacji :
Journal Article
MeSH Terms :
Transendothelial and Transepithelial Migration*
Heart Arrest/*pathology
Inflammation/*etiology
Leukocytes, Mononuclear/*cytology
Semaphorins/*physiology
Animals ; Case-Control Studies ; Cell Movement ; Cells, Cultured ; Endothelial Cells/metabolism ; Humans ; Mice ; Neuropilin-2/metabolism ; Platelet Endothelial Cell Adhesion Molecule-1/metabolism ; Resuscitation ; Transcellular Cell Migration
Czasopismo naukowe
Tytuł :
Impaired SIRT3 activity mediates cardiac dysfunction in endotoxemia by calpain-dependent disruption of ATP synthesis.
Autorzy :
Koentges C; Heart Center Freiburg University, Department of Cardiology and Angiology, Freiburg, Germany.
Cimolai MC; Heart Center Freiburg University, Department of Cardiology and Angiology, Freiburg, Germany; Departamento de Ciencias Básicas, Universidad Nacional de Luján, CONICET, Luján, Buenos Aires, Argentina.
Pfeil K; Heart Center Freiburg University, Department of Cardiology and Angiology, Freiburg, Germany.
Wolf D; Heart Center Freiburg University, Department of Cardiology and Angiology, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Marchini T; Heart Center Freiburg University, Department of Cardiology and Angiology, Freiburg, Germany; Institute of Biochemistry and Molecular Medicine, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.
Tarkhnishvili A; Heart Center Freiburg University, Department of Cardiology and Angiology, Freiburg, Germany.
Hoffmann MM; Faculty of Medicine, University of Freiburg, Freiburg, Germany; Institute for Clinical Chemistry and Laboratory Medicine, Medical Center - University of Freiburg, Germany.
Odening KE; Heart Center Freiburg University, Department of Cardiology and Angiology, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Diehl P; Heart Center Freiburg University, Department of Cardiology and Angiology, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
von Zur Mühlen C; Heart Center Freiburg University, Department of Cardiology and Angiology, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Alvarez S; Institute of Biochemistry and Molecular Medicine, School of Pharmacy and Biochemistry, University of Buenos Aires, Buenos Aires, Argentina.
Bode C; Heart Center Freiburg University, Department of Cardiology and Angiology, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Zirlik A; Heart Center Freiburg University, Department of Cardiology and Angiology, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany; Division of Cardiology, Medical University of Graz, Graz, Austria.
Bugger H; Heart Center Freiburg University, Department of Cardiology and Angiology, Freiburg, Germany; Faculty of Medicine, University of Freiburg, Freiburg, Germany; Division of Cardiology, Medical University of Graz, Graz, Austria. Electronic address: .
Pokaż więcej
Źródło :
Journal of molecular and cellular cardiology [J Mol Cell Cardiol] 2019 Aug; Vol. 133, pp. 138-147. Date of Electronic Publication: 2019 Jun 13.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenosine Triphosphate/*biosynthesis
Calpain/*metabolism
Endotoxemia/*complications
Heart Diseases/*etiology
Heart Diseases/*metabolism
Sirtuin 3/*metabolism
Animals ; Calpain/antagonists & inhibitors ; Cytokines ; Disease Models, Animal ; Endotoxemia/etiology ; Enzyme Activation ; Heart Diseases/physiopathology ; Humans ; Male ; Mice ; Mice, Knockout ; Mitochondria, Heart/metabolism ; Myocytes, Cardiac/metabolism ; Oxidative Stress ; Sepsis/complications ; Sepsis/etiology ; Signal Transduction ; Sirtuin 3/genetics
Czasopismo naukowe
Tytuł :
Moderate ischemic mitral regurgitation: coronary artery bypass grafting with versus without simultaneous treatment of the mitral valve.
Autorzy :
Rilinger J; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany - .
Heilmann C; University of Cooperative Education, Plauen, Germany.
Beitinger U; Department of Cardiovascular Surgery, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Olivier CB; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Diehl P; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Beyersdorf F; Department of Cardiovascular Surgery, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Siepe M; Department of Cardiovascular Surgery, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Pokaż więcej
Źródło :
The Journal of cardiovascular surgery [J Cardiovasc Surg (Torino)] 2018 Dec; Vol. 59 (6), pp. 830-835. Date of Electronic Publication: 2018 Mar 12.
Typ publikacji :
Comparative Study; Journal Article; Observational Study
MeSH Terms :
Coronary Artery Bypass*/adverse effects
Coronary Artery Bypass*/mortality
Heart Valve Prosthesis Implantation*/adverse effects
Heart Valve Prosthesis Implantation*/mortality
Mitral Valve Annuloplasty*/adverse effects
Mitral Valve Annuloplasty*/mortality
Mitral Valve/*surgery
Mitral Valve Insufficiency/*surgery
Myocardial Ischemia/*surgery
Aged ; Aged, 80 and over ; Female ; Germany ; Hemodynamics ; Humans ; Male ; Middle Aged ; Mitral Valve/diagnostic imaging ; Mitral Valve/physiopathology ; Mitral Valve Insufficiency/diagnostic imaging ; Mitral Valve Insufficiency/mortality ; Mitral Valve Insufficiency/physiopathology ; Myocardial Ischemia/diagnostic imaging ; Myocardial Ischemia/mortality ; Myocardial Ischemia/physiopathology ; Retrospective Studies ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł :
The effect of oxygen in Sirt3-mediated myocardial protection: a proof-of-concept study in cultured cardiomyoblasts.
Autorzy :
Diehl P; Department of Cardiology & Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
Gaul DS; Department of Cardiology, University Heart Center Zurich, University Hospital Zurich, Ramistr. 100, 8098, Zurich, Switzerland.
Sogl J; Department of Cardiology & Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
Flierl U; Baker IDI Heart and Diabetes Institute, Melbourne, Australia.; Hannover Medical School, Hanover, Germany.
Henstridge D; Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
Pahla J; Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.
Bugger H; Department of Cardiology & Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Emmert MY; Swiss Center for Regenerative Medicine, University of Zurich, Zurich, Switzerland.
Ruschitzka F; Department of Cardiology, University Heart Center Zurich, University Hospital Zurich, Ramistr. 100, 8098, Zurich, Switzerland.
Bode C; Department of Cardiology & Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Lüscher TF; Department of Cardiology, University Heart Center Zurich, University Hospital Zurich, Ramistr. 100, 8098, Zurich, Switzerland.; Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland.; Zurich Center for Human Integrative Physiology (ZHIP), University of Zurich, Zurich, Switzerland.
Moser M; Department of Cardiology & Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Matter CM; Department of Cardiology, University Heart Center Zurich, University Hospital Zurich, Ramistr. 100, 8098, Zurich, Switzerland.; Swiss Center for Regenerative Medicine, University of Zurich, Zurich, Switzerland.; Zurich Center for Human Integrative Physiology (ZHIP), University of Zurich, Zurich, Switzerland.
Peter K; Department of Cardiology & Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
Winnik S; Department of Cardiology, University Heart Center Zurich, University Hospital Zurich, Ramistr. 100, 8098, Zurich, Switzerland. .; Center for Molecular Cardiology, University of Zurich, Zurich, Switzerland. .
Pokaż więcej
Źródło :
Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2018 Jul; Vol. 46 (1), pp. 102-112.
Typ publikacji :
Journal Article
MeSH Terms :
Myoblasts/*cytology
Oxygen/*pharmacology
Protective Agents/*pharmacology
Sirtuin 3/*pharmacology
Cell Line ; Cell Respiration ; Humans ; Myocardium/metabolism ; Myocytes, Cardiac
Czasopismo naukowe
Tytuł :
A ligand-specific blockade of the integrin Mac-1 selectively targets pathologic inflammation while maintaining protective host-defense.
Autorzy :
Wolf D; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.; Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 92037, USA.
Anto-Michel N; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Blankenbach H; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Wiedemann A; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Buscher K; Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 92037, USA.
Hohmann JD; Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, 8008, VIC, Australia.
Lim B; Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, 8008, VIC, Australia.
Bäuml M; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Marki A; Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 92037, USA.
Mauler M; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Duerschmied D; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Fan Z; Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 92037, USA.
Winkels H; Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 92037, USA.
Sidler D; Division of Nephrology, Inselspital, Bern University Hospital, Bern, 3010, Switzerland.
Diehl P; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Zajonc DM; Division of Cell Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 92037, USA.
Hilgendorf I; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Stachon P; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Marchini T; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Willecke F; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Schell M; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.; Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 92037, USA.
Sommer B; Neurosurgery, Medical Faculty of the University of Erlangen, Erlangen, 91054, Germany.
von Zur Muhlen C; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Reinöhl J; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Gerhardt T; Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 92037, USA.
Plow EF; Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Yakubenko V; Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, 44195, USA.
Libby P; Brigham and Women's Hospital, Cardiovascular Medicine, Harvard Medical School, Boston, MA, 02115, USA.
Bode C; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Ley K; Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 92037, USA.
Peter K; Atherothrombosis and Vascular Biology, Baker Heart and Diabetes Institute, Melbourne, 8008, VIC, Australia. .
Zirlik A; Cardiology and Angiology I, University Heart Center, and Medical Faculty, University of Freiburg, Freiburg, 79106, Germany.
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2018 Feb 06; Vol. 9 (1), pp. 525. Date of Electronic Publication: 2018 Feb 06.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Antibodies, Monoclonal/*pharmacology
Inflammation/*drug therapy
Macrophage-1 Antigen/*metabolism
Molecular Targeted Therapy/*methods
Animals ; Binding Sites ; CD40 Ligand/metabolism ; Host-Pathogen Interactions/drug effects ; Humans ; Inflammation/pathology ; Leukocytes/drug effects ; Leukocytes/pathology ; Male ; Mice, Inbred C57BL ; Neutrophils/drug effects ; Sepsis/drug therapy
Czasopismo naukowe
Tytuł :
Coronary magnetic resonance imaging after routine implantation of bioresorbable vascular scaffolds allows non-invasive evaluation of vascular patency.
Autorzy :
von Zur Mühlen C; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Reiss S; Department of Radiology-Medical Physics, University Medical Center Freiburg, Freiburg, Germany.
Krafft AJ; Department of Radiology-Medical Physics, University Medical Center Freiburg, Freiburg, Germany.
Besch L; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Menza M; Department of Radiology-Medical Physics, University Medical Center Freiburg, Freiburg, Germany.
Zehender M; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Heidt T; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Maier A; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Pfannebecker T; ABBOTT Vascular, Wetzlar, Germany.
Zirlik A; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Reinöhl J; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Stachon P; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Hilgendorf I; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Wolf D; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Diehl P; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Wengenmayer T; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Ahrens I; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Bode C; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Bock M; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Freiburg, Germany.; Department of Radiology-Medical Physics, University Medical Center Freiburg, Freiburg, Germany.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2018 Jan 25; Vol. 13 (1), pp. e0191413. Date of Electronic Publication: 2018 Jan 25 (Print Publication: 2018).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Absorbable Implants*/adverse effects
Vascular Patency*
Angina Pectoris/*diagnostic imaging
Angina Pectoris/*etiology
Magnetic Resonance Angiography/*methods
Percutaneous Coronary Intervention/*adverse effects
Aged ; Humans ; Imaging, Three-Dimensional/methods ; Middle Aged ; Polyesters ; Tissue Scaffolds/adverse effects ; Tissue Scaffolds/chemistry
Czasopismo naukowe
Tytuł :
Endothelial BMP4 Regulates Leukocyte Diapedesis and Promotes Inflammation.
Autorzy :
Helbing T; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany. .
Arnold L; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Wiltgen G; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Hirschbihl E; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Gabelmann V; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Hornstein A; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Esser JS; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Diehl P; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Grundmann S; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Busch HJ; Department of Emergency Medicine, University Hospital of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Fink K; Department of Emergency Medicine, University Hospital of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Bode C; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Moser M; Department of Cardiology and Angiology I, Heart Center Freiburg University, Faculty of Medicine, University of Freiburg, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.
Pokaż więcej
Źródło :
Inflammation [Inflammation] 2017 Dec; Vol. 40 (6), pp. 1862-1874.
Typ publikacji :
Journal Article
MeSH Terms :
Inflammation*/etiology
Transendothelial and Transepithelial Migration*
Antigens, CD/*physiology
Bone Morphogenetic Protein 4/*physiology
Cadherins/*physiology
Leukocytes/*metabolism
Chemotaxis, Leukocyte ; Endothelium, Vascular/metabolism ; Heart Arrest/pathology ; Human Umbilical Vein Endothelial Cells ; Humans
Czasopismo naukowe
Tytuł :
Bone Morphogenetic Protein-Modulator BMPER Regulates Endothelial Barrier Function.
Autorzy :
Helbing T; Department of Cardiology and Angiology, Heart Center Freiburg University, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany. .; Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany. .
Wiltgen G; Department of Cardiology and Angiology, Heart Center Freiburg University, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.; Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Hornstein A; Department of Cardiology and Angiology, Heart Center Freiburg University, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.; Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Brauers EZ; Department of Cardiology and Angiology, Heart Center Freiburg University, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.; Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Arnold L; Department of Cardiology and Angiology, Heart Center Freiburg University, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.; Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Bauer A; Department of Cardiology and Angiology, Heart Center Freiburg University, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.; Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Esser JS; Department of Cardiology and Angiology, Heart Center Freiburg University, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.; Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Diehl P; Department of Cardiology and Angiology, Heart Center Freiburg University, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.; Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Grundmann S; Department of Cardiology and Angiology, Heart Center Freiburg University, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.; Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Fink K; Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.; Department of Emergency Medicine, University Hospital of Freiburg, Freiburg im Breisgau, Germany.
Patterson C; McAllister Heart Institute, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.; New York-Presbyterian Hospital, New York City, NY, 10065, USA.
Bode C; Department of Cardiology and Angiology, Heart Center Freiburg University, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.; Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Moser M; Department of Cardiology and Angiology, Heart Center Freiburg University, Hugstetter Strasse 55, 79106, Freiburg im Breisgau, Germany.; Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.
Pokaż więcej
Źródło :
Inflammation [Inflammation] 2017 Apr; Vol. 40 (2), pp. 442-453.
Typ publikacji :
Journal Article
MeSH Terms :
Carrier Proteins/*physiology
Endothelium, Vascular/*physiology
Animals ; Antigens, CD/metabolism ; Bone Morphogenetic Protein 4/administration & dosage ; Bone Morphogenetic Protein 4/metabolism ; Bone Morphogenetic Proteins/metabolism ; Cadherins/metabolism ; Capillary Permeability/drug effects ; Carrier Proteins/genetics ; Humans ; Mice ; Mice, Inbred C57BL ; RNA, Small Interfering/pharmacology ; Signal Transduction
Czasopismo naukowe
Tytuł :
High platelet reactivity after P2Y12-inhibition in patients with atrial fibrillation and coronary stenting.
Autorzy :
Rilinger J; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Meyer M; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Schnabel K; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Weik P; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Charlet A; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Esser JS; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Zhou Q; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Bode C; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Moser M; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Diehl P; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany.
Olivier CB; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg, Germany. .
Pokaż więcej
Źródło :
Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2016 Nov; Vol. 42 (4), pp. 558-65.
Typ publikacji :
Clinical Trial; Comparative Study; Journal Article; Observational Study
MeSH Terms :
Atrial Fibrillation*/blood
Atrial Fibrillation*/therapy
Receptors, Purinergic P2Y12*
Stents*
Thromboembolism*/blood
Thromboembolism*/prevention & control
Blood Platelets/*metabolism
Platelet Activation/*drug effects
Platelet Aggregation Inhibitors/*administration & dosage
Aged ; Aged, 80 and over ; Coronary Vessels ; Drug Therapy, Combination ; Female ; Humans ; Male ; Risk Factors
Czasopismo naukowe
Tytuł :
Dabigatran and rivaroxaban do not affect AA- and ADP-induced platelet aggregation in patients receiving concomitant platelet inhibitors.
Autorzy :
Olivier CB; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg - Bad Krozingen, Germany. .
Weik P; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg - Bad Krozingen, Germany.
Meyer M; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg - Bad Krozingen, Germany.
Weber S; Center for Medical Biometry and Medical Informatics, Medical Center - University of Freiburg, Freiburg, Germany.
Diehl P; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg - Bad Krozingen, Germany.
Bode C; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg - Bad Krozingen, Germany.
Moser M; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg - Bad Krozingen, Germany.
Zhou Q; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg - Bad Krozingen, Germany.
Pokaż więcej
Źródło :
Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2016 Aug; Vol. 42 (2), pp. 161-6.
Typ publikacji :
Journal Article; Observational Study
MeSH Terms :
Dabigatran/*pharmacology
Platelet Aggregation/*drug effects
Platelet Aggregation Inhibitors/*therapeutic use
Rivaroxaban/*pharmacology
Adenosine Diphosphate/metabolism ; Antithrombins/pharmacology ; Antithrombins/therapeutic use ; Arachidonic Acid/metabolism ; Clopidogrel ; Dabigatran/therapeutic use ; Drug Therapy, Combination ; Humans ; Rivaroxaban/therapeutic use ; Ticlopidine/analogs & derivatives
Czasopismo naukowe
Tytuł :
Platelet reactivity after administration of third generation P2Y12-antagonists does not depend on body weight in contrast to clopidogrel.
Autorzy :
Olivier CB; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg - Bad Krozingen, Germany. .
Schnabel K; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg - Bad Krozingen, Germany.
Weber S; Center for Medical Biometry and Medical Informatics, Medical Center - University Freiburg, Freiburg, Germany.
Zhou Q; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg - Bad Krozingen, Germany.
Bode C; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg - Bad Krozingen, Germany.
Moser M; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg - Bad Krozingen, Germany.
Diehl P; Cardiology and Angiology I, Heart Center, Freiburg University, Hugstetter Str. 55, 79106, Freiburg - Bad Krozingen, Germany.
Pokaż więcej
Źródło :
Journal of thrombosis and thrombolysis [J Thromb Thrombolysis] 2016 Jul; Vol. 42 (1), pp. 84-9.
Typ publikacji :
Journal Article
MeSH Terms :
Body Weight*
Platelet Activation/*drug effects
Purinergic P2Y Receptor Antagonists/*administration & dosage
Adenosine/administration & dosage ; Adenosine/analogs & derivatives ; Clopidogrel ; Dose-Response Relationship, Drug ; Drug Dosage Calculations ; Humans ; Platelet Aggregation/drug effects ; Prasugrel Hydrochloride/administration & dosage ; Purinergic P2Y Receptor Antagonists/pharmacology ; Purinergic P2Y Receptor Antagonists/therapeutic use ; Ticagrelor ; Ticlopidine/administration & dosage ; Ticlopidine/analogs & derivatives
Czasopismo naukowe
Tytuł :
The Ratio of ADP- to TRAP-Induced Platelet Aggregation Quantifies P2Y12-Dependent Platelet Inhibition Independently of the Platelet Count.
Autorzy :
Olivier CB; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Meyer M; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Bauer H; Munich University Hospital, Institute and Outpatient Clinic for Occupational, Social, and Environmental Medicine, Munich, Germany.
Schnabel K; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Weik P; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Zhou Q; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Bode C; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Moser M; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Diehl P; Heart Center Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Pokaż więcej
Źródło :
PloS one [PLoS One] 2016 Feb 17; Vol. 11 (2), pp. e0149053. Date of Electronic Publication: 2016 Feb 17 (Print Publication: 2016).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Adenosine Diphosphate/*pharmacology
Oligopeptides/*pharmacology
Platelet Aggregation/*drug effects
Receptors, Purinergic P2Y12/*metabolism
Aged ; Biomarkers/metabolism ; Female ; Humans ; Male ; Platelet Count ; Regression Analysis
Czasopismo naukowe
Tytuł :
TRAP-induced platelet aggregation is enhanced in cardiovascular patients receiving dabigatran.
Autorzy :
Olivier CB; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany. Electronic address: .
Weik P; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Meyer M; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Weber S; Center for Medical Biometry and Medical Informatics, Medical Center - University of Freiburg, Freiburg, Germany.
Anto-Michel N; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Diehl P; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Zhou Q; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Geisen U; Medical Center-University of Freiburg, Institute for Clinical Chemistry and Laboratory Medicine, Freiburg, Germany.
Bode C; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Moser M; Heart Center, Freiburg University, Cardiology and Angiology I, Freiburg-Bad Krozingen, Germany.
Pokaż więcej
Źródło :
Thrombosis research [Thromb Res] 2016 Feb; Vol. 138, pp. 63-68. Date of Electronic Publication: 2015 Nov 01.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Antithrombins/*therapeutic use
Atrial Fibrillation/*drug therapy
Blood Platelets/*drug effects
Dabigatran/*therapeutic use
Platelet Aggregation/*drug effects
Receptors, Thrombin/*metabolism
Rivaroxaban/*therapeutic use
Aged ; Aged, 80 and over ; Antithrombins/pharmacology ; Dabigatran/pharmacology ; Female ; Humans ; Male ; Middle Aged ; Pulmonary Embolism/drug therapy ; Rivaroxaban/pharmacology ; Venous Thrombosis/drug therapy
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies